IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Anavex Life Sciences COR

Q2 2025 vs Q3 2025

Comparing institutional holders between quarters

Quarters

Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Byrne Asset Management LLC
UNCHANGED
Shares6,400 from 6,400
Change0 (0%)
Value$57.0K (-$2.0K)
Filed 2025-10-22
Status
Byrne Asset Management LLC
UNCHANGED6,4006,40000%$59.0K$57.0K-$2.0K2025-10-22
Showing 1 of 1 institutions